Molecure S.A.

WSE:MOC 주식 보고서

시가총액: zł165.8m

Molecure 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Marcin Szumowski

최고 경영자

zł473.2k

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권0.7%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간2.8yrs

최근 관리 업데이트

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO

Marcin Szumowski

no data

테뉴어

zł473,205

보상

Dr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...


리더십 팀

이름위치테뉴어보상소유권
Marcin Szumowski
Co-Founderno datazł473.21k0.70%
PLN 1.2m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł421.09k0.20%
PLN 339.9k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.8yrszł473.21k0.11%
PLN 186.1k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.8yrszł348.41k0.034%
PLN 57.1k
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.8yrszł500.00k3.01%
PLN 5.0m
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno data데이터 없음데이터 없음
Piotr Iwanowski
Chief Medical Officer & Member of Management Boardless than a year데이터 없음데이터 없음
Magdalena Tyszkiewicz
Head of CMC4.8yrs데이터 없음데이터 없음
Marta Borkowska
Director of the Management Board Office2.8yrs데이터 없음데이터 없음

3.8yrs

평균 재임 기간

경험이 풍부한 관리: MOC 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Luke O'Neill
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Reynold A. Panettieri
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Bart Lambrecht
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Tomasz Piec
Vice Chairman of the Supervisory Board4.8yrszł133.62k데이터 없음
Douglas Hay
Member of Scientific Advisory Boardno data데이터 없음데이터 없음
Paul Van Der Horst
Independent Chairman of the Supervisory Board2.8yrszł132.99k0.059%
PLN 98.5k
Nancy Van Osselaer
Independent Member of the Supervisory Board2.8yrszł124.22k데이터 없음
Agnieszka Motyl
Member of the Supervisory Board1.3yrszł44.45k데이터 없음
Pawel Trawkowski
Independent Member of the Supervisory Board2.4yrszł124.22k데이터 없음

2.8yrs

평균 재임 기간

경험이 풍부한 이사회: MOC 의 이사회경험(평균 재직 기간 2.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.